Top

Neurological Sciences

Published in:

01-06-2019 | Cerebral Small Vessel Disease | Original Article

The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment

Authors: Xueyun Liu, Tan Li, Shanshan Diao, Xiuying Cai, Yan Kong, Lulu Zhang, Zhuo Wang, Runnan Li, Yun Zhou, Qi Fang

Published in: Neurological Sciences | Issue 6/2019

Abstract

Background and purpose

Various types of cerebral small vessel diseases (CSVD) are commonly coexisting and the clinical outcome possibly is determined by their combined effect. The present study was designed to explore the possible relationship between the global burden of CSVD and clinical outcomes after recombinant tissue plasminogen activator (rt-PA) treatment of ischemic stroke.

Methods

We enrolled patients with acute ischemic stroke (AIS) after IV rt-PA treatment between August 2016 and July 2018. According to the total burden rating scale of CSVD, we calculated the total CSVD score for white matter hyperintensities, lacunar infarction, cerebral microbleeds, and perivascular spaces. All patients were assessed on the basis of the National Institutes of Health Stroke Scale (NIHSS) score and the modified Rankin Scale (mRS) score at 90 days after stroke. We used multivariate logistic regression analysis to examine the associations between global burden of CSVD and degree of neurological deficit and clinical outcomes. ROC curve analysis was used to determine cut-off values of the total CSVD score in predicting poor outcomes.

Results

The results showed that the total CSVD score was independently associated with moderate to severe stroke (OR 2.187, 95%CI 1.495–3.119, P < 0.001). Initial NIHSS (OR 1.23, 95%CI 1.144–1.330, P < 0.001), OTT (OR 1.007, 95%CI 1.000–1.014, P = 0.037), and CSVD score (OR 3.157, 95%CI 2.120–4.703, P < 0.001) was significantly related to poor functional outcome at 3 months. The total CVSD score cut-off value of 1.5 was determined at best to distinguish between good prognosis and poor outcome (AUC 0.7534 [95%CI 0.6883–0.8185]).

Conclusions

The global burden of CSVD was independently associated with neurological deficit severity and clinical outcomes of AIS after IV rt-PA treatment. The total CVSD score is a reliable predictor for poor outcomes of AIS after IV rt-PA treatment.

Khoshnam SE, Winlow W, Farzaneh M, Farbood Y, Moghaddam HF (2017) Pathogenic mechanisms following ischemic stroke. Neurol Sci 38(7):1167–1186. https://doi.org/10.1007/s10072-017-2938-1 CrossRefPubMed

Tejada-Meza H, Modrego PJ (2017) Cerebellar vermis: a vulnerable location of remote brain haemorrhages after thrombolysis for ischaemic stroke. Neurol Sci 38(1):185–187. https://doi.org/10.1007/s10072-016-2728-1 CrossRefPubMed

Wardlaw JM, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12(5):483–497. https://doi.org/10.1016/S1474-4422(13)70060-7 CrossRefPubMed

Shi Y, Wardlaw JM (2016) Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol 1(3):83–92. https://doi.org/10.1136/svn-2016-000035 CrossRefPubMedPubMedCentral

Inzitari D (2003) Leukoaraiosis: an independent risk factor for stroke? Stroke 34(8):2067–2071. https://doi.org/10.1161/01.STR.0000080934.68280.82 CrossRefPubMed

Rajani RM, Williams A (2017) Endothelial cell-oligodendrocyte interactions in small vessel disease and aging. Clin Sci 131(5):369–379. https://doi.org/10.1042/CS20160618 CrossRefPubMedPubMedCentral

Hainsworth AH, Fisher MJ (2017) A dysfunctional blood-brain barrier and cerebral small vessel disease. Neurology 88(5):420–421. https://doi.org/10.1212/WNL.0000000000003561 CrossRefPubMed

Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJ, van Buchem MA, Wardlaw JM (2016) Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab 36(10):1653–1667. https://doi.org/10.1177/0271678X16662891 CrossRefPubMedPubMedCentral

Henninger N, Lin E, Haussen DC, Lehman LL, Takhtani D, Selim M, Moonis M (2013) Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke 44(1):61–67. https://doi.org/10.1161/STROKEAHA.112.679084 CrossRefPubMed

10.

Ay H, Arsava EM, Rosand J, Furie KL, Singhal AB, Schaefer PW, Wu O, Gonzalez RG, Koroshetz WJ, Sorensen AG (2008) Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 39(5):1409–1413. https://doi.org/10.1161/STROKEAHA.107.501932 CrossRefPubMed

11.

Henninger N, Khan MA, Zhang J, Moonis M, Goddeau RP Jr (2014) Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion. Stroke 45(3):689–695. https://doi.org/10.1161/STROKEAHA.113.002855 CrossRefPubMed

12.

Helenius J, Henninger N (2015) Leukoaraiosis burden significantly modulates the association between infarct volume and National Institutes of Health stroke scale in ischemic stroke. Stroke 46(7):1857–1863. https://doi.org/10.1161/STROKEAHA.115.009258 CrossRefPubMed

13.

Liu Y, Gong P, Sun H, Zhang S, Zhou J, Zhang Y (2019) Leukoaraiosis is associated with poor outcomes after successful recanalization for large vessel occlusion stroke. Neurol Sci. https://doi.org/10.1007/s10072-018-3698-2

14.

Curtze S, Haapaniemi E, Melkas S, Mustanoja S, Putaala J, Sairanen T, Sibolt G, Tiainen M, Tatlisumak T, Strbian D (2015) White matter lesions double the risk of post-thrombolytic intracerebral hemorrhage. Stroke 46(8):2149–2155. https://doi.org/10.1161/STROKEAHA.115.009318 CrossRefPubMed

15.

Zand R, Tsivgoulis G, Singh M, McCormack M, Goyal N, Ishfaq MF, Shahripour RB, Nearing K, Elijovich L, Alexandrov AW, Liebeskind DS, Alexandrov AV (2017) Cerebral microbleeds and risk of intracerebral hemorrhage post intravenous thrombolysis. J Stroke Cerebrovasc Dis 26(3):538–544. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.127 CrossRefPubMed

16.

Huijts M, Duits A, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Staals J (2013) Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. A study in first-ever lacunar stroke and hypertensive patients. Front Aging Neurosci 5:72. https://doi.org/10.3389/fnagi.2013.00072 CrossRefPubMedPubMedCentral

17.

Staals J, Booth T, Morris Z, Bastin ME, Gow AJ, Corley J, Redmond P, Starr JM, Deary IJ, Wardlaw JM (2015) Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging 36(10):2806–2811. https://doi.org/10.1016/j.neurobiolaging.2015.06.024 CrossRefPubMedPubMedCentral

18.

Brenner D, Labreuche J, Pico F, Scheltens P, Poirier O, Cambien F, Amarenco P, Investigators G (2008) The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol 255(7):993–1000. https://doi.org/10.1007/s00415-008-0816-8 CrossRefPubMed

19.

Pico F, Labreuche J, Touboul PJ, Leys D, Amarenco P (2005) Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol 57(4):472–479. https://doi.org/10.1002/ana.20423 CrossRefPubMed

20.

Klarenbeek P, van Oostenbrugge RJ, Rouhl RP, Knottnerus IL, Staals J (2013) Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke 44(11):2995–2999. https://doi.org/10.1161/STROKEAHA.113.002545 CrossRefPubMed

21.

Uiterwijk R, van Oostenbrugge RJ, Huijts M, De Leeuw PW, Kroon AA, Staals J (2016) Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension. Front Aging Neurosci 8:301. https://doi.org/10.3389/fnagi.2016.00301 CrossRefPubMedPubMedCentral

22.

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, nEuroimaging STfRVco (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12(8):822–838. https://doi.org/10.1016/S1474-4422(13)70124-8 CrossRefPubMedPubMedCentral

23.

Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM (2010) Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 41(3):450–454. https://doi.org/10.1161/STROKEAHA.109.564914 CrossRef

24.

Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149(2):351–356. https://doi.org/10.2214/ajr.149.2.351 CrossRef

25.

Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM (2014) Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 83(14):1228–1234. https://doi.org/10.1212/WNL.0000000000000837 CrossRefPubMedPubMedCentral

26.

Arba F, Inzitari D, Ali M, Warach SJ, Luby M, Lees KR, Collaboration SVI (2017) Small vessel disease and clinical outcomes after IV rt-PA treatment. Acta Neurol Scand 136(1):72–77. https://doi.org/10.1111/ane.12745 CrossRefPubMed

27.

Lau KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, Cheung RTF, Kuker W, Mak HKF, Rothwell PM (2017) Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts. Neurology 88(24):2260–2267. https://doi.org/10.1212/WNL.0000000000004042 CrossRefPubMedPubMedCentral

28.

Bandettini di Poggio M, Finocchi C, Brizzo F, Altomonte F, Bovis F, Mavilio N, Serrati C, Malfatto L, Mancardi G, Balestrino M (2019) Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome. Neurol Sci 40(2):319–326. https://doi.org/10.1007/s10072-018-3644-3 CrossRefPubMed

29.

Abdul-Rahim AH, Fulton RL, Sucharew H, Kleindorfer D, Khatri P, Broderick JP, Lees KR, Collaborators V (2015) National institutes of health stroke scale item profiles as predictor of patient outcome: external validation on independent trial data. Stroke 46(2):395–400. https://doi.org/10.1161/STROKEAHA.114.006837 CrossRefPubMed

30.

Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD (1999) Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53(1):126–131CrossRefPubMed

31.

Yaghi S, Willey JZ, Cucchiara B, Goldstein JN, Gonzales NR, Khatri P, Kim LJ, Mayer SA, Sheth KN, Schwamm LH, American Heart Association Stroke C, Council on C, Stroke N, Council on Clinical C, Council on Quality of C, Outcomes R (2017) Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(12):e343–e361. https://doi.org/10.1161/STR.0000000000000152 CrossRefPubMed

32.

Yaghi S, Eisenberger A, Willey JZ (2014) Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol 71(9):1181–1185. https://doi.org/10.1001/jamaneurol.2014.1210 CrossRefPubMedPubMedCentral

Title: The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment
Authors: Xueyun Liu
Tan Li
Shanshan Diao
Xiuying Cai
Yan Kong
Lulu Zhang
Zhuo Wang
Runnan Li
Yun Zhou
Qi Fang
Publication date: 01-06-2019
Publisher: Springer International Publishing
Keywords: Cerebral Small Vessel Disease
Stroke
Published in: Neurological Sciences / Issue 6/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-03790-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment

Abstract

Background and purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background and purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2019

Italian recommendations for the diagnosis and treatment of myasthenia gravis

Clinical, radiological features and surgical strategies for 23 NF1 patients with intraorbital meningoencephalocele

A review of electrophysiological studies of lower motor neuron involvement in amyotrophic lateral sclerosis

Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson’s disease

Intestinal barrier dysfunction following traumatic brain injury

Cortical and spinal excitability changes after repetitive transcranial magnetic stimulation combined to physiotherapy in stroke spastic patients